Boston Scientific Receives FDA Approval for Next-Generation WATCHMAN FLX Left Atrial Appendage Closure Device

All Editors: Andrew M. Goldsweig, MD, MSC, RPVI, FSCAI

Other Specialist Resources for Structural Heart Disease

Including recently published studies, coverage of late-breaking science, updates from clinical trials and registries, and complex case presentations.

Clinical Interest Article

Outcomes of Mitral Transcatheter Edge-to-Edge Repair in Patients with Mitral Annular Calcification—Coverage of SCAI Scientific Sessions 2026

Clinical Interest Article

AltaValve Early Feasibility Study: One-Year Outcomes with Atrial Fixation Transcatheter Mitral Valve Replacement—Coverage of SCAI Scientific Sessions 2026

Clinical Interest Article

TRISCEND II: Two-Year Outcomes of Transcatheter Tricuspid Valve Replacement for Severe Tricuspid Regurgitation—Coverage of ACC 2026

Clinical Interest Article

Transcatheter Aortic Valve Implantation Without Routine Percutaneous Coronary Intervention—Coverage of ACC 2026

Clinical Interest Article

CHAMPION-AF Primary Results: Outcomes in Patients With Atrial Fibrillation Randomized to Receive Left Atrial Appendage Closure or Oral Anticoagulation—Coverage of ACC 2026

Clinical Interest Article

Health Status Outcomes Seven Years After TAVR/SAVR in Low Surgical Risk Patients With Severe Aortic Stenosis (PARTNER 3 Substudy)—Coverage of CRT 2026

SCAI^® is a registered trademark of the Society for Cardiovascular Angiography & Interventions.

All content found on the Society for Cardiovascular Angiography & Interventions website (www.scai.org) including text, images, audio, video, or other formats is created for informational purposes only. Links to other content are to be taken at your own risk. SCAI is not responsible for the content or claims of external websites.

Connect